Internal Medicine · Rockville Centre, NY
NPI
1841231545
Since 2006
Specialty
Internal Medicine
Code 207R00000X
Group practices
2
Medicare group memberships
Hospitals
1
Hospital affiliations
178 Sunrise Hwy
Rockville Centre, NY, 11570
Phone (516) 536-5765
Groups this clinician bills Medicare through
Medicare paid, 2024
$400K
6,204 services
Medicare patients, 2024
309
Average age 74
Drug cost, 2024
$1.4M
12,055 prescriptions
Company payments, 2025
$783
From 17 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Reza S Naghavi was code 99490 (chronic, principal, and transitional care management), 1,239 times for 236 patients. In total Reza S Naghavi billed 6,204 services in 78 codes, and Medicare paid $400K.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2013-04-18.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| 99490 Chronic, Principal, and Transitional Care Management | Office | 1,239 | 236 | $53.22 | $66K |
| 99214 Office E&M - Established | Office | 1,134 | 277 | $106.42 | $121K |
| G0447 Face-to-face behavioral counseling for obesity, 15 minutes | Office | 395 | 127 | $27.97 | $11K |
| 96372 Injection Administration | Office | 302 | 191 | $12.87 | $3,886 |
| 94060 Pulmonary Function Testing | Office | 254 | 182 | $33.21 | $8,435 |
| 94640 Treatment - Miscellaneous | Office | 249 | 182 | $7.12 | $1,773 |
| 99213 Office E&M - Established | Office | 248 | 144 | $77.32 | $19K |
| G0442 Annual alcohol misuse screening, 5 to 15 minutes | Office | 195 | 194 | $21.58 | $4,209 |
| 93000 Electrocardiogram | Office | 181 | 151 | $12.33 | $2,232 |
| G0439 Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 146 | 146 | $147.45 | $22K |
| 99443 Telephone Services | Office | 137 | 76 | $104.28 | $14K |
| G0444 Annual depression screening, 5 to 15 minutes | Office | 137 | 135 | $21.35 | $2,924 |
| G3002 Chronic pain management and treatment, monthly bundle including, diagnosis; assessment and monitoring; administration of a validated pain rating scale or tool; the development, implementation, revision, and/or maintenance of a person-centered care plan tha | Office | 136 | 99 | $74.02 | $10K |
| G0446 Annual, face-to-face intensive behavioral therapy for cardiovascular disease, individual, 15 minutes | Office | 131 | 131 | $28.38 | $3,718 |
| 99497 Care Management/Coordination | Office | 126 | 126 | $73.45 | $9,254 |
By year: 2022 $140K for 1,913 services; 2023 $303K for 4,521 services; 2024 $400K for 6,204 services.
Lab tests billed to Medicare, 2024
| Test code | Tests | Patients | Paid per test | Medicare paid |
|---|---|---|---|---|
| 87804 Immunoassay | 76 | 34 | $16.22 | $1,233 |
| 87426 Immunoassay | 41 | 36 | $34.62 | $1,419 |
Medicare prescription drug claims, 2024
In 2024, the drug Reza S Naghavi prescribed most often to Medicare patients was Famotidine, with 524 prescriptions and refills. In total Reza S Naghavi wrote 12,055 Medicare prescriptions that cost $1.4M.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Famotidine Generic | 524 | 1,042 | 184 | $9,131 |
| Lidocaine Generic | 435 | 520 | 75 | $46K |
| Atorvastatin Calcium Generic | 414 | 1,116 | 170 | $3,540 |
| Diclofenac Sodium Generic | 409 | 419 | 87 | $50K |
| Meloxicam Generic | 378 | 435 | 163 | $1,354 |
| Losartan Potassium Generic | 336 | 921 | 133 | $3,632 |
| Amlodipine Besylate Generic | 310 | 801 | 107 | $1,608 |
| Rosuvastatin Calcium Generic | 304 | 812 | 132 | $3,767 |
| Levothyroxine Sodium Generic | 266 | 721 | 93 | $4,145 |
| Felodipine Er Felodipine | 261 | 690 | 102 | $8,373 |
| Vitamin D2 Ergocalciferol (Vitamin D2) | 248 | 504 | 109 | $2,192 |
| Alprazolam Generic | 231 | 231 | 60 | $1,003 |
| Escitalopram Oxalate Generic | 203 | 483 | 74 | $2,208 |
| Simvastatin Generic | 201 | 549 | 76 | $1,129 |
| Fluticasone Propionate Generic | 192 | 204 | 101 | $1,806 |
Brand drugs: 1,367 claims; generic drugs: 10,621 claims; opioid claims: 198.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Reza S Naghavi $783 ($783 in general payments such as food, travel and fees) from 17 companies. The largest payer was GlaxoSmithKline, LLC. with $278.
| Company | Payments | Amount |
|---|---|---|
| GlaxoSmithKline, LLC. GSK | 16 | $278 |
| Tempus AI, Inc TEM | 3 | $72.29 |
| Novo Nordisk Inc NVO | 3 | $56.63 |
| Amgen Inc. AMGN | 2 | $46.31 |
| Corcept Therapeutics CORT | 2 | $43.36 |
| Exact Sciences Corporation EXAS | 2 | $38.08 |
| Lilly USA, LLC LLY | 2 | $30.74 |
| Eisai Inc. 4523.T | 1 | $28.36 |
| Takeda Pharmaceuticals U.S.A., Inc. TAK | 1 | $25.94 |
| Renalytix AI, Inc. | 1 | $22.81 |
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.